United States · Series A startup

Who invested in Magnet Biomedicine

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$50Mraised across 1 round since 2023, from 1 source

Latest round
Series A, $50MSept 2023
Investors
1
See who backed them

The rounds

  1. Sept 2023
    Series A$50M

    Source recorded

Founders and team

From Magnet Biomedicine's own website: 8 on the team.

  • Bharat ReddyVice President of Drug Discovery
  • Jennifer FranklinVice President of Operations
  • Mabel LeeVice President, Clinical Operations
  • Brian SafinaChief Medical Officer
  • Nick VlahakisChief Business Officer
  • Rajesh MenonVP, Regulatory Affairs
  • Danielle ThibaultOffice Manager
  • Super PresenterLead Op

AdvisersBenjamin F. CravattDavid A. SpiegelJordan ZwickMichael RosbashRamnik XavierRicha Saxena

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Quick answers about Magnet Biomedicine

Who invested in Magnet Biomedicine?

Magnet Biomedicine's investors include ARCH Venture Partners.

How much has Magnet Biomedicine raised?

Magnet Biomedicine has raised $50M across 1 round since 2023.

When did Magnet Biomedicine last raise?

Magnet Biomedicine's most recent round was a Series A of $50M in Sept 2023.

What was Magnet Biomedicine's biggest round?

Its most recent round, $50M in Sept 2023, is also its largest on record.

Who backed Magnet Biomedicine first?

Magnet Biomedicine's first round on record, in Sept 2023, was backed by ARCH Venture Partners.

What stage is Magnet Biomedicine at?

Magnet Biomedicine's latest named round is a Series A, in Sept 2023.

Where is Magnet Biomedicine based?

Magnet Biomedicine is based in the United States.

Companies like Magnet Biomedicine

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.